Fluoroquinolone-resistantEscherichia coli, Indonesia
Authors:
- Kuntaman KuntamanKKKuntaman Kuntaman
- Ni Made MertaniasihNMNi Made Mertaniasih
- Usman HadiUHUsman Hadi
- Alex van BelkumABAlex van Belkum
- On Behalf Of The Antimicrobial Resistance In IndonesiaOIOn Behalf Of The Antimicrobial Resistance In Indonesia
- Prevalence and Prevention study groupPGPrevalence and Prevention study group
Open Access
- 1 September 2005
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 11 (9) , 1363-1369
Abstract
In a recent, population-based survey of 3,996 persons in Indonesia, fluoroquinolone (FQ)-resistant Escherichia coli was prevalent in the fecal flora of 6% of patients at hospital admission and 23% of patients at discharge, but not among healthy relatives or patients visiting primary healthcare centers (2%). Molecular typing showed extensive genetic diversity with only limited clonality among isolates. This finding suggests that independent selection of resistant mutants occurs frequently. FQ-resistant isolates exhibited a higher rate of spontaneous mutation, but sparser virulence profiles, than FQ-susceptible isolates from the same population. The resistant isolates belonged predominantly to phylogenetic groups A (57%) and B1 (22%) but also to the moderately virulent group D (20%). Hypervirulent strains from the B2 cluster were underrepresented (1%). Because FQ-resistant E. coli can cause disease, especially nosocomial infections in immunocompromised patients, spread of such strains must be stopped.Keywords
This publication has 23 references indexed in Scilit:
- Virulence Factor Profiles and Phylogenetic Background ofEscherichia coliIsolates from Veterans with Bacteremia and Uninfected Control SubjectsThe Journal of Infectious Diseases, 2004
- Relationship between ciprofloxacin resistance and extended-spectrum β-lactamase production in Escherichia coli and Klebsiella pneumoniae strainsClinical Microbiology and Infection, 2004
- Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 2003
- Phylogenetic Origin and Virulence Genotype in Relation to Resistance to Fluoroquinolones and/or Extended‐Spectrum Cephalosporins and Cephamycins amongEscherichia coliIsolates from Animals and HumansThe Journal of Infectious Diseases, 2003
- Both Urinary and Rectal Escherichia coli Isolates Are Dominated by Strains of Phylogenetic Group B2Journal of Clinical Microbiology, 2002
- Emergence of Reduced Susceptibility and Resistance to Fluoroquinolones in Escherichia coli in Taiwan and Contributions of Distinct Selective PressuresAntimicrobial Agents and Chemotherapy, 2001
- Rapid Emergence of Ciprofloxacin-Resistant Enterobacteriaceae Containing Multiple Gentamicin Resistance-Associated Integrons, the NetherlandsEmerging Infectious Diseases, 2001
- Rapid Emergence of Ciprofloxacin-Resistant Enterobacteriaceae Containing Multiple Gentamicin Resistance-Associated Integrons, the NetherlandsEmerging Infectious Diseases, 2001
- Proposal for a New Inclusive Designation for Extraintestinal Pathogenic Isolates ofEscherichia coli:ExPECThe Journal of Infectious Diseases, 2000
- Extended Virulence Genotypes ofEscherichia coliStrains from Patients with Urosepsis in Relation to Phylogeny and Host CompromiseThe Journal of Infectious Diseases, 2000